IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Dcvc Opportunity Fund II GP, LLC

Q3 2025 Holdings

Filed 2025-11-14 | 1 holdings | $19.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Recursion Pharmaceuticals, Inc.(RXRX)CL A75629V104$19.3M3,951,141100.0%